Target intelligence / Profile preview

Acyl-protein thioesterase 2 (LYPLA2)

Target
LYPLA2
Molecular classification
Enzyme, Hydrolase
01

Overview

Acyl-protein thioesterase 2 (LYPLA2) is an enzyme with hydrolase activity that regulates membrane lipid composition and protein localization by hydrolyzing fatty acids from S-acylated cysteine residues of various proteins, such as certain G protein subunits, HRAS, and GAP43[1][2]. It also acts as a lysophospholipase, catalyzing the removal of acyl groups from lysophospholipids, and participates in the hydrolysis of prostaglandin glycerol esters, implicating it in lipid mediator metabolism and cell signaling[1][2][4]. LYPLA2 plays a crucial role in lipid homeostasis and cellular signaling, and its dysfunction is associated with several neurological and degenerative diseases[1][2][4]. Its paralog, LYPLA1, has overlapping but non-redundant functions.

Other names
Lysophospholipase IIAPT2LPL-IILysoPLA IIpalmitoyl-protein hydrolaseDJ886K2.4testicular tissue protein Li 3
02

Mechanism of action

Inhibitors prevent hydrolysis of fatty acyl moieties from proteins, altering protein localization and function. Modulation of lysophospholipid and prostaglandin metabolism, affecting lipid-mediated signaling pathways.

03

Biological functions

Depalmitoylation of proteins (removal of fatty acids from S-acylated cysteine residues)Lysophospholipase activity (hydrolysis of lysophospholipids)Hydrolysis of prostaglandin glycerol estersLipid metabolism and homeostasis regulationRegulation of cellular membrane structure and protein localization
04

Disease associations

Neurodegenerative diseases (e.g., Neuronal ceroid lipofuscinosis)Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataractPotential roles in cancer, based on function in cell signaling and MAPK pathway modulation
05

Safety considerations

Potential cellular toxicity and membrane disruption due to altered lysophospholipid metabolism if inhibited or deletedPhenotypic and morphological cellular changes observed when both LYPLA1 and LYPLA2 are deleted in model systems[2]
06

Interacting drugs

ML349
07

Biomarkers

no widely recognized clinical biomarkers directly associated with LYPLA2 at this time

Beyond the preview

Go deeper on Acyl-protein thioesterase 2 (LYPLA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acyl-protein thioesterase 2 (LYPLA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call